Ha! If EMSOA aren't in the money by December then I can only assume the report won't be out yet, directors won't have put any money where their mouth is and BP still won't be resolved.
My point being, with EMS you lose it all, with EMSOA you only lose half. At that point, you can use the remaining half of your capital to buy in to the headstock around the 1-2c level.
Only risk? The director options have a timing differential that they could game if they wanted: Delay the report until Jan, bridging load against the sale of a finished product and then make a motza on their options without EMSOA dilution. That's what I would do. But then again, I'm a complete cu
EMS Price at posting:
2.8¢ Sentiment: None Disclosure: Held